Related references
Note: Only part of the references are listed.Treadmill exercise reverses dendritic spine loss in direct and indirect striatal medium spiny neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease
William A. Toy et al.
NEUROBIOLOGY OF DISEASE (2014)
Dynamic Interaction between Sigma-1 Receptor and Kv1.2 Shapes Neuronal and Behavioral Responses to Cocaine
Said Kourrich et al.
CELL (2013)
Altered localization, abnormal modification and loss of function of Sigma receptor-1 in amyotrophic lateral sclerosis
J. Prause et al.
HUMAN MOLECULAR GENETICS (2013)
Sigma-1 Receptor Enhances Neurite Elongation of Cerebellar Granule Neurons via TrkB Signaling
Yuriko Kimura et al.
PLOS ONE (2013)
Microglia and macrophages of the central nervous system: the contribution of microglia priming and systemic inflammation to chronic neurodegeneration
V. Hugh Perry et al.
SEMINARS IN IMMUNOPATHOLOGY (2013)
Fluoxetine rescues impaired hippocampal neurogenesis in a transgenic A53T synuclein mouse model
Zacharias Kohl et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2012)
Fluoxetine ameliorates behavioral and neuropathological deficits in a transgenic model mouse of α-synucleinopathy
Kiren Ubhi et al.
EXPERIMENTAL NEUROLOGY (2012)
Neuroprotective effects of the sigma-1 receptor ligand PRE-084 against excitotoxic perinatal brain injury in newborn mice
E. Griesmaier et al.
EXPERIMENTAL NEUROLOGY (2012)
Sigma-1R Agonist Improves Motor Function and Motoneuron Survival in ALS Mice
Renzo Mancuso et al.
NEUROTHERAPEUTICS (2012)
Effects of the Sigma-1 Receptor Agonist 1-(3,4-Dimethoxyphenethyl)-4-(3-Phenylpropyl)-Piperazine Dihydro-Chloride on Inflammation after Stroke
Karsten Ruscher et al.
PLOS ONE (2012)
α-Synuclein-Induced Down-Regulation of Nurr1 Disrupts GDNF Signaling in Nigral Dopamine Neurons
Mickael Decressac et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Sigma-1 receptor chaperones regulate the secretion of brain-derived neurotrophic factor
Michiko Fujimoto et al.
SYNAPSE (2012)
The sigma-1 receptor: roles in neuronal plasticity and disease
Said Kourrich et al.
TRENDS IN NEUROSCIENCES (2012)
The cholinergic system, sigma-1 receptors and cognition
Aren van Waarde et al.
BEHAVIOURAL BRAIN RESEARCH (2011)
The sigma-1 receptor enhances brain plasticity and functional recovery after experimental stroke
Karsten Ruscher et al.
BRAIN (2011)
Anti-amnesic and neuroprotective potentials of the mixed muscarinic receptor/sigma1 (σ1) ligand ANAVEX2-73, a novel aminotetrahydrofuran derivative
Vanessa Villard et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Behavioural phenotyping of knockout mice for the sigma-1 (σ1) chaperone protein revealed gender-related anxiety, depressive-like and memory alterations
Nathalie Chevallier et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to L-DOPA in the 6-hydroxydopamine mouse model of Parkinson's disease
Veronica Francardo et al.
NEUROBIOLOGY OF DISEASE (2011)
Sigma receptor ligand 4-phenyl-1-(4-phenylbutyl)-piperidine modulates neuronal nitric oxide synthase/postsynaptic density-95 coupling mechanisms and protects against neonatal ischemic degeneration of striatal neurons
Zeng-Jin Yang et al.
EXPERIMENTAL NEUROLOGY (2010)
l-DOPA-induced dopamine efflux in the striatum and the substantia nigra in a rat model of Parkinson's disease: temporal and quantitative relationship to the expression of dyskinesia
Hanna S. Lindgren et al.
JOURNAL OF NEUROCHEMISTRY (2010)
Sigma-1 Receptors Regulate Bcl-2 Expression by Reactive Oxygen Species-Dependent Transcriptional Regulation of Nuclear Factor κB
Johann Meunier et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Neuroinflammation in Parkinson's disease: Its role in neuronal death and implications for therapeutic intervention
Malu G. Tansey et al.
NEUROBIOLOGY OF DISEASE (2010)
THE SIGMA-1 RECEPTOR IS ENRICHED IN POSTSYNAPTIC SITES OF C-TERMINALS IN MOUSE MOTONEURONS. AN ANATOMICAL AND BEHAVIORAL STUDY
T. A. Mavlyutov et al.
NEUROSCIENCE (2010)
The sigma-1 receptor chaperone as an inter-organelle signaling modulator
Tsung-Ping Su et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2010)
Sigma-1 receptor knockout mice display a depressive-like phenotype
Valentina Sabino et al.
BEHAVIOURAL BRAIN RESEARCH (2009)
Stepping test in mice: A reliable approach in determining forelimb akinesia in MPTP-induced Parkinsonism
Shannon R. Blume et al.
EXPERIMENTAL NEUROLOGY (2009)
Neuroinflammation in Parkinson's disease: a target for neuroprotection?
Etienne C. Hirsch et al.
LANCET NEUROLOGY (2009)
The pharmacology of sigma-1 receptors
Tangui Maurice et al.
PHARMACOLOGY & THERAPEUTICS (2009)
Sigma-1 receptors regulate hippocampal dendritic spine formation via a free radical-sensitive mechanism involving Rac1.GTP pathway
Shang-Yi Tsai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Low density of sigma1 receptors in early Alzheimer's disease
Masahiro Mishina et al.
ANNALS OF NUCLEAR MEDICINE (2008)
Characterization of the striatal 6-OHDA model of Parkinson's disease in wild type and α-synuclein-deleted mice
Daniel Alvarez-Fischer et al.
EXPERIMENTAL NEUROLOGY (2008)
Neuroinflammation and synaptic plasticity: theoretical basis for a novel, immune-centred, therapeutic approach to neurological disorders
Massimiliano Di Filippo et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2008)
Apolipoprotein D is elevated in oligodendrocytes in the peri-infarct region after experimental stroke: influence of enriched environment
Mattias Rickhag et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2008)
Sigma-1 receptor chaperones at the ER-Mitochondrion interface regulate Ca2+ signaling and cell survival
Teruo Hayashi et al.
CELL (2007)
Sigma receptor agonists provide neuroprotection in vitro by preserving bcl-2
Sufang Yang et al.
ANESTHESIA AND ANALGESIA (2007)
Glial-derived neurotrophic factor (GDNF) prevents ethanol (EtOH) induced B92 glial cell death by both PI3K/AKT and MEK/ERK signaling pathways
Santiago Nahuel Villegas et al.
BRAIN RESEARCH BULLETIN (2006)
Oncoprotein Akt/PKB induces trophic effects in murine models of Parkinson's disease
Vincent Ries et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Endothelial proliferation and increased blood-brain barrier permeability in the basal ganglia in a rat model of 3,4-dihydroxyphenyl-L-alanine-induced dyskinesia
Jenny E. Westin et al.
JOURNAL OF NEUROSCIENCE (2006)
Sigma 1 receptor agonists act as neuroprotective drugs through inhibition of inducible nitric oxide synthase
Kamila Vagnerova et al.
ANESTHESIA AND ANALGESIA (2006)
Sigma receptor activation reduces infarct size at 24 hours after permanent middle cerebral artery occlusion in rats
Craig T. Ajmo et al.
CURRENT NEUROVASCULAR RESEARCH (2006)
Does contraversive circling in the 6-OHDA-lesioned rat indicate an ability to induce motor complications as well as therapeutic effects in Parkinson's disease?
EL Lane et al.
EXPERIMENTAL NEUROLOGY (2006)
Glial cell line-derived neurotrophic factor promotes the arborization of cultured striatal neurons through the p42/p44 mitogen-activated protein kinase pathway
JM Garcia-Martinez et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2006)
Interplay between PI3K/Akt and MAPK signaling pathways in DNA-damaging drug-induced apoptosis
Eung-Ryoung Lee et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2006)
Brain-derived growth factor and glial cell line-derived growth factor use distinct intracellular signaling pathways to protect PD cybrids from H2O2-induced neuronal death
IG Onyango et al.
NEUROBIOLOGY OF DISEASE (2005)
Involvement of the sigma1 receptor in the modulation of dopaminergic transmission by amantadine
M Peeters et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2004)
σ-1 receptors (σ1 binding sites) form raft-like microdomains and target lipid droplets on the endoplasmic reticulum:: Roles in endoplasmic reticulum lipid compartmentalization and export
T Hayashi et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Intracellular dynamics of σ-1 receptors (σ1 binding sites) in NG108-15 cells
T Hayashi et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Somatodendritic dopamine release in rat substantia nigra influences motor performance on the accelerating rod
F Bergquist et al.
BRAIN RESEARCH (2003)
Animal models of neurological deficits: how relevant is the rat?
MA Cenci et al.
NATURE REVIEWS NEUROSCIENCE (2002)
Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease
M Lundblad et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2002)
Involvement of inducible nitric oxide synthase in inflammation-induced dopaminergic neurodegeneration
MM Iravani et al.
NEUROSCIENCE (2002)
Neuroinflammation of the nigrostriatal pathway during progressive 6-OHDA dopamine degeneration in rats monitored by immunohistochemistry and PET imaging
F Cicchetti et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2002)
Neuroprotective effect of σ1-receptor ligand 4-phenyl-1-(4-phenylbutyl) piperidine (PPBP) is linked to reduced neuronal nitric oxide production
T Goyagi et al.
STROKE (2001)
Transcription-dependent and -independent control of neuronal survival by the PI3K-Akt signaling pathway
A Brunet et al.
CURRENT OPINION IN NEUROBIOLOGY (2001)
σ1-receptor ligand 4-phenyl-1-(4-phenylbutyl)-piperidine affords neuroprotection from focal ischemia with prolonged reperfusion
I Harukuni et al.
STROKE (2000)
Immunocytochemical localization of the sigma(1) receptor in the adult rat central nervous system
G Alonso et al.
NEUROSCIENCE (2000)
CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury
T Schallert et al.
NEUROPHARMACOLOGY (2000)
Share Paper
